Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 598 results for "Byetta"

Human medicines European public assessment report (EPAR): By...

This is a summary of the European public assessment report (EPAR) for Byetta. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 2 weeks ago

2 images for "Byetta"

PRWeb, 1 day ago
PR inside, 3 weeks ago

Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report

Hundreds of Byetta lawsuits ( and other product liability claims involving a class of Type 2 diabetes drugs known as incretin mimetics continue to move forward in a federal multidistrict litigation now underway in ...
 Digital Journal1 day ago Diabetes Drug Litigation Prepares to Discuss Byetta Lawsuits, Claims over Similar Products at December Conference, Bernstein Liebhard LLP Reports  Digital Journal2 weeks ago ASTRAZENECA : New Order Issued in Federal Incretin Mimetic Litigation, Where Hundreds of Byetta Lawsuits and other Diabetes Drug Claims Have Been Filed  4 Traders2 weeks ago New Order Issued in Federal Incretin Mimetic Litigation, Where Hundreds of Byetta Lawsuits and other Diabetes Drug Claims Have Been Filed  Red Orbit2 weeks ago

exenatide, Byetta

Pharmacy Author: Omudhome Ogbru, PharmD Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University ...
 MedicineNet.com2 days ago Why These Big Pharma Stocks Could Plunge  Motley Fool3 weeks ago
MedPage Today

The Slippery Slope: Adverse Events and Runaway Diabetes Train

Diabetes drugs have been linked to thousands of deaths and hospitalizations over the last decade, a MedPage Today/Milwaukee Journal Sentinel investigation found -- but there is little ability to measure the true risk of the drugs. That's ...
 MedPage Today9 hours ago

Legal-Bay Lawsuit Settlement Funding Reports Readiness to Fund all Settled Cases within 12 Hours of Applying

Case Funding Firm is prepared for the holiday rush and stands ready to approve all settled cases within 12 hours of applying; also lists all general cases eligible for the 24-hour approval process bef... (December 18, 2014) BRONX, N.Y., Dec. 18, ...
 Review Seeker4 days ago
Jutia Group

Market Update: Bristol-Myers Squibb Company (NYSE:BMY) Bristol-Myers Squibb to Announce Results for Fourth Quarter, Full Year 2014 on January 27

[Business Wire] Bristol-Myers Squibb Company will announce results for the fourth quarter and full year of 2014 on Tuesday, January 27, 2015. During a conference call at 9 a.m. EST on J Read more on this. Bristol-Myers Squibb Company (BMY) , ...
 Jutia Group5 days ago Stock Update: Bristol-Myers Squibb Company (NYSE:BMY) Multiple Bristol-Myers Squibb Oncology Compounds to be Featured in Oral Presentations at 56th Annual American Society for Hematology (ASH) Meeting  Jutia Group1 month ago

RD Legal Funding Can Accelerate Delayed Settled Case Fees to Plaintiffs' Attorneys with Pharmaceutical Cases

CRESSKILL, N.J., Dec. 16, 2014 /PRNewswire/ -- RD Legal Funding, LLC ("RD Legal"), an industry leader in the post-settlement finance space, can now provide funding to plaintiffs' attorneys whose fees are delayed in pharmaceutical cases. These cases ...
 TickerTech.com6 days ago

Patient access to novel non-insulin treatments is sub-optimal in China

With respect to the treatment of type 2 diabetes in China, patient access to premium-priced agents is impeded as not all patients can afford these drugs, according to new research findings. The National Reimbursement Drug List was last updated in ...
 Pharma Letter2 weeks ago The Type 2 Diabetes Population will Continue to Expand in China, But Patient Access to Novel Non-Insulin Treatments is Sub-Optimal  Vision Monday2 weeks ago

Fusion protein of Exendin-4 and its analog, preparation method and use thereof

Provided are a fusion protein of Exendin-4 and its analog, the preparation method and use thereof. The fusion protein is obtained by fusing of Exendin-4 or its analog to Fc region of human IgG2 via a linking peptide, which has the better stability ...
 PharmCast2 weeks ago
Jutia Group

Market Update (NYSE:BMY): Bristol-Myers Squibb Foundation Marks World AIDS Day by Awarding $1.47 Million in New Grants to Strengthen HIV-Related Services in Five Sub-Saharan Countries

[Business Wire] The Bristol-Myers Squibb Foundation today marked World AIDS Day by announcing 12 new grants totaling $1.47 million that focus on strengthening community-based services in sub-Sahar Read more on this. Bristol-Myers Squibb ...
 Jutia Group3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less